Brands are showing up, consumers expect them to
Danette Breitenbach
Build for the long-term, responsibly
Danette Breitenbach
Trending
Show more
Subscribe & Follow
Advertise your job vacancies
Jobs
- Account Operations Coordinator Johannesburg
- Used Gear and Rentals Liaison Cape Town
- Customer Services Representative Johannesburg
- Junior Bookkeeper Johannesburg
- U-turn – Retail Area Manager Cape Town
- Brand Ambassador Hazyview
- Sales Coordinator Cape Town
- Store Manager - Sales Pretoria
- Assistant Store Manager - Sales Johannesburg
- Cashiers / Shop Assistants Johannesburg
Nestlé to acquire biopharmaceutical company Aimmune
Nestlé Health Science (NHSc) is to acquire Aimmune Therapeutics in accordance with a definitive agreement between Nestlé and the biopharmaceutical company.
NHSc currently has a total investment in Aimmune of $473m, an approximate 25.6% equity ownership stake. The company made its initial investment of $145m in Aimmune in November 2016, followed by further investments of $30m in February 2018, $98m in November 2018 and $200m in January 2020.
